Urgent.News

the world's headlines, one feed

Editions

Business

Economy: US job market shrinks surprisingly in July

The US job market weakened in July contrary to expectations. Companies created 23,000 fewer jobs. This is likely to have an impact on interest rate expectations.

Translated from German Read in German

Economy: US job market shrinks surprisingly in July

In July, the US labor market experienced a surprising cooling effect, shedding 23,000 positions outside of agriculture, according to a government report released on Friday. Economists polled by the news agency Reuters had expected job growth of 80,000. June data, revised afterward, showed only a 20,000 job increase, originally reported at 57,000.

The separate unemployment rate decreased in July to 4.1%, down from 4.2% in June. The US Federal Reserve, which aims for full employment and stable prices, has been closely monitoring the labor market. They maintained the federal funds rate within the range of 3.50 to 3.75% and recently announced that job growth remains sluggish, with the unemployment rate showing signs of stabilization. Inflation remains higher than previously reported.

Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.

Read the original at handelsblatt.com →

More in Business

MSS Prepares Ulchi Exercise to Sustain SME Support

The “2026 Ulchi Exercise,” aimed at maintaining government functions and ensuring public safety in the event of a national emergency, will be conducted from Aug. 18 to 21.

  • Ministry of SMEs and Startups prepares for 2026 Ulchi Exercise.
  • Exercise evaluates support for SMEs during national emergencies.
  • Focus on cyberterrorism and Chungmu Plan sustainability.

Samsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Pre-filled Syringe Across Europe

Samsung Bioepis Co., Ltd. today announced the launch of OPUVIZ™ 40 mg/mL solution in pre-filled syringe (PFS), a biosimilar referencing Eylea1(aflibercept), across Europe, starting today.“We are…

  • Samsung Bioepis launches OPUVIZ™ 40 mg/mL pre-filled syringe in Europe.
  • Vice President Antonio Rito praises convenience and precision of new format.
  • OPUVIZ approved for wet AMD, macular edema, diabetic edema, and choroidal neovascularisation.